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During exocytosis, vesicles in secretory cells fuse with
the cellular membrane and release their contents in
a Ca2-dependent process. Release occurs initially
through a fusion pore, and its rate is limited by the
dissociation of the matrix-associated contents. To deter-
mine whether this dissociation is promoted by osmotic
forces, we have examined the effects of elevated osmotic
pressure on release and extrusion from vesicles at mast
and chromaffin cells. The identity of the molecules re-
leased and the time course of extrusion were measured
with fast scan cyclic voltammetry at carbon fiber micro-
electrodes. In external solutions of high osmolarity, re-
lease events following entry of divalent ions (Ba2 or
Ca2) were less frequent. However, the vesicles ap-
peared to be fused to the membrane without extruding
their contents, since the maximal observed concentra-
tions of events were less than 7% of those evoked in
isotonic media. Such an isolated, intermediate fusion
state, which we term “kiss-and-hold,” was confirmed by
immunohistochemistry at chromaffin cells. Transient
exposure of cells in the kiss and hold state to isotonic
solutions evoked massive release. These results demon-
strate that an osmotic gradient across the fusion pore is
an important driving force for exocytotic extrusion of
granule contents from secretory cells following fusion
pore formation.
Vesicles in secretory cells perform two different functions:
they are a storage depot for small molecules and they release
these molecules during exocytosis. Storage in dense core vesi-
cles requires stable packaging for an extended period of time.
This is accomplished by association of the vesicular contents.
On the other hand, release requires dissociation of this storage
matrix on a relatively fast time scale so the contents can be
extruded (1, 2).
In mast cells, histamine and 5-HT are associated with a
negatively charged heparin matrix in the vesicles through a
cation exchange type of interaction (3). These vesicles contain
150 mM histamine, which alone with its associated anion would
lead to a free osmolality of 550 mosM (4). However, the vesi-
cles are iso-osmotic with the 300-mosM cytoplasm because of
the association of the molecules within the granule matrix (5).
Similarly, a single chromaffin cell vesicle contains 550 mM
catecholamine along with 122 mM ATP, 17–30 mM Ca2, 5 mM
Mg2, 22 mM ascorbate, and the acidic protein chromogranin A,
leading to a total soluble concentration of 750 mM (6). Again,
molecular associations lead to a state (7, 8) that is iso-osmotic
with the cytoplasm (6). These close associations have been
documented by nuclear magnetic resonance in vesicles from
both cell types (9, 10).
Upon cell stimulation, the vesicle contacts the plasma mem-
brane and forms a fusion pore, the dynamics and control of
which have been reviewed recently (11, 12). Capacitance and
amperometry techniques have indicated that a portion of the
vesicular contents can be released through this fusion pore (13,
14). Furthermore, at both mast and chromaffin cells, patch-
amperometry measurements reveal that the fusion pore can
exist for several milliseconds prior to full extrusion of vesicle
contents (15, 16). Following secretory vesicle-cell membrane
fusion in mast cells vesicular swelling occurs (17), which has
been attributed to the displacement of associated cations in the
granule with hydrated cations such as Na from the external
solution (18). This ion exchange mechanism, with its associated
hydration effects (19), has been hypothesized and experimen-
tally supported at several cell types as reviewed by Artalejo
et al. (20).
Theoretical considerations of this process have likened the
extrusion and swelling to a controlled explosion that drives full
release of the vesicular contents and dissociation of the vesic-
ular matrix (18). Amperometric recordings revealed that the
time course of release is longer than that expected for free
diffusion (1), having a duration of several milliseconds at chro-
maffin cells (21, 22), and even longer at mast cells (23), con-
sistent with a rate-limiting dissociation. The time course of
extrusion can be decreased by perturbing any of the physical
and chemical gradients that exist between the vesicle interior
and the extracellular environment. These include osmolarity,
pH, and cation concentration (24–26). For example, increasing
the osmotic gradient by lowering the extracellular solution
osmolarity decreases the release time course and increases the
amount released, whereas high extracellular osmolarity has
the opposite effect (27). In the present work, the effects of high
osmolarity (using elevated NaCl) on secretory cells were eval-
uated in an attempt to freeze exocytotic events at the step
between fusion pore formation and extrusion of vesicle con-
tents. The results reported are consistent with such a state and
reveal that extrusion of the vesicular contents is a distinct step
in the sequence of events termed exocytosis.
EXPERIMENTAL PROCEDURES
Cell Culture—Bovine adrenal medullary cells, enriched in either
epinephrine or norepinephrine using a Renografin gradient, were cul-
tured as previously described and plated at a density of 3  105 cells/
plate (28). Cells were used on days 3–7 after culture. Murine peritoneal
mast cells were cultured as described previously (29). Cells were plated
on 25-mm glass coverslips (Carolina Biological Supply, Burlington, NC)
contained in 35-mm diameter tissue culture plates (Falcon; Fisher
Scientific).
Electrochemistry—Carbon fiber microelectrodes for the detection of
released molecules were prepared as described (30). Electrodes were
* The costs of publication of this article were defrayed in part by the
payment of page charges. This article must therefore be hereby marked
“advertisement” in accordance with 18 U.S.C. Section 1734 solely to
indicate this fact.
‡ To whom correspondence should be addressed. Tel.: 919-962-1472;
Fax: 919-962-2388; E-mail: rmw@unc.edu.
THE JOURNAL OF BIOLOGICAL CHEMISTRY Vol. 277, No. 32, Issue of August 9, pp. 29101–29107, 2002
© 2002 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in U.S.A.
This paper is available on line at http://www.jbc.org 29101
This is an Open Access article under the CC BY license.
backfilled with a 4 M potassium acetate, 150 mM KCl solution and
calibrated using 4 M epinephrine, norepinephrine, and histamine and
1 M serotonin. FSCV1 was performed using locally written Labview
software (National Instruments, Austin, TX) with an EI-400 poten-
tiostat (Cypress Systems, Lawrence, KS) (31). Potentials were scanned
from 200 mV to 1600 mV and back for catecholamines and from
100 to 1400 mV and back for histamine and serotonin (potentials
versus a Ag/AgCl reference electrode, Bioanalytical Systems, Lafayette,
IN). A scan rate of 2000 V/s was used with a 60-Hz repetition rate. Spike
detection and analysis at the peak oxidation potentials for the mole-
cules of interest were performed (32), and the resulting current spike
amplitudes were converted to concentration based on electrode
calibrations.
Cell Experiments—Individual cells were stimulated to release by
pressure ejection (Picospritzer; General Valve Corp., Fairfield, NJ) of 5
mM BaCl2 or 60 mM KCl (chromaffin cells), 0.5 M A23187 (mast cells),
or transient isotonic buffer solution (chromaffin and mast cells) from a
micropipette placed 30 m from the cell. The carbon fiber microelec-
trode was placed 1 m from the cell membrane using a piezoelectric
manipulator (PCS-1000, Burleigh Instruments, Fishers, NY) on the
stage of an inverted microscope (Axiovert 35; Zeiss, Thornwood, NY).
Cells were rinsed with isotonic Tris-HCl buffer at room temperature
prior to experiment. For experiments in which bathing buffer osmolar-
ity was changed, glass coverslips containing the cells were placed in a
perfusion chamber positioned on the microscope.
Confocal Microscopy—DH labeling was used to visualize events
associated with exocytosis at chromaffin cells. To measure surface-
bound DH, a measure of cell membrane-vesicle fusion, cells were
exposed to 5 mM Ba2 for 2 min in Tris-HCl buffer (no added Ca2) in
iso- or hypertonic buffer. Control cells were incubated without Ba2.
The cells were then fixed with a non-permeant protocol by quickly
removing the bathing solutions and replacing them with identical buff-
ers containing 4% p-formaldehyde at 4 °C for 20 min (33). The cells were
then rinsed twice with buffer, incubated with 0.2% bovine serum albu-
min for 10 min, rinsed two more times, and incubated with mouse
anti-DH monoclonal antibody (1:300; Chemicon, Temecula, CA) for 45
min at 4 °C. To monitor DH retention on the surface, an identical
procedure was followed except the cells were incubated in iso- or hy-
pertonic buffer for 20 min following Ba2 but before fixation. To monitor
vesicle recycling, the procedure was again identical except the anti-
DH antibody was present during the exposure to Ba2. These cells
were fixed and permeabilized with ethanol to allow visualization of
endocytosed DH.
After rinsing, DH was visualized by incubating the cells with Alexa-
Fluor 568 goat anti-mouse IgG conjugate (1:1000, Molecular Probes,
Eugene, OR). The coverslips containing the cells were washed and
mounted on microscope slides with Vectashield (Vector Labs, Burl-
ingame, CA). Images were acquired using a 100 oil immersion objec-
tive on a Leica-LCS confocal microscope (Leica Instruments, Exton,
PA). Analysis of images was performed using Scion Image software
(Frederick, MD).
Mast Cell Optical Imaging—Visualization of release from mast cells
was enhanced with 50 g/ml ruthenium red (29). Individual cells in
both iso-osmotic and elevated osmolarity buffers were stimulated to
release and monitored using a CCD camera (Sensys, Photometrics,
Tucson, AZ) through the microscope.
Reagents and Solutions—All chemicals were obtained from Sigma
and used as received. A23187 was prepared by 1000-fold dilution of a
stock solution in Me2SO. Iso-osmotic buffer contained 12.5 mM Tris-
HCl, 150 mM NaCl, 4 mM KCl, 1.2 mM MgCl2, and 5 mM glucose).
Hypertonic buffers were prepared by elevating the NaCl concentration
to 520 mM for chromaffin cells and 350 mM for mast cells. All solutions
were prepared using doubly distilled deionized water and adjusted to
pH 7.4 by addition of NaOH.
RESULTS
Mast Cells—Following transient exposure (5 s) to the Ca2
ionophore A23187 in isotonic buffer (150 mM NaCl), mast cells
exhibited frequent exocytotic release events that were detected
by cyclic voltammetry (Table I), consistent with previous re-
ports. Every exocytotic event resulted in the simultaneous re-
lease of 5-HT and histamine (Fig. 1) that each gave a distinct
voltammetric peak (29). Each event was characterized by a
simultaneous increase in the concentrations of 5-HT and his-
tamine followed by a more gradual returned to base line. Oc-
casionally the exocytotic spikes were preceded by a foot-like
event (29) in which a transient, steady-state, low concentration
of the amine was present (data not shown). Such events have
been shown to be due to secretion through the fusion pore (13).
Mast cells displayed greater sensitivity to elevations in os-
molarity than chromaffin cells. Application of external solution
with NaCl concentrations of 520 mM, as used with chromaffin
cells (see below), caused either complete inhibition of Ca2-
evoked release events or rapid, spontaneous degranulation. At
a lower NaCl concentration (350 mM NaCl), only a few cells
degranulated spontaneously. However, for intact cells, release
was quite dramatically altered. Exposure to A23187 in hyper-
tonic medium containing Ca2 still evoked spikes, but their
maximal concentration was 1% of that evoked in isotonic
solution. Indeed, they resemble feet unaccompanied by spikes.
The frequency of spikes was also reduced (Table I). Spikes with
large concentrations could be obtained if the cells were subse-
quently exposed to an isotonic puff for a transient (5 s) period
3 min after the initial A23187 exposure (an example is shown
in Fig. 1). After the exposure to isotonic buffer, the spikes
continued for as long as 5 min at a frequency similar to that in
isotonic buffer (Table I).
Since the average diameter of mast cell vesicles is 700 nm
(29), the degranulation that occurs during exocytosis can be
observed with light microscopy. In hypertonic medium, the
mast cells shrank and degranulation was not apparent upon
application of A23187 (Fig. 2b). This was the case despite the
fact that the voltammetric results showed spikes of histamine
and 5-HT (Fig. 1), albeit small ones. However, degranulation
was readily observed immediately after transient application of
isotonic buffer, and it continued for the time scale of the release
detected with voltammetry (Fig. 2, c and d).
The lack of visual degranulation is not due to failure of Ca2
to enter the cell. Ca2 entry was immediate upon exposure to
A23187 in hypertonic buffer as revealed by fluorescence from
fura-2, the ratiometric divalent ion indicator (34). Further-
more, upon exposure to isotonic buffer, the larger spikes, with
their accompanying visual degranulation, were not accompa-
nied by a further influx of Ca2 (Fig. 1, upper trace). Thus, in
hypertonic solution, it appears that Ca2 entry evokes vesicle-
cell membrane fusion, but extrusion of vesicular contents is
suppressed unless isotonic conditions are restored for a tran-
sient period.
1 The abbreviations used are: FSCV, fast scan cyclic voltammetry;
DH, dopamine--hydroxylase; 5-HT, 5-hydroxytryptamine.
TABLE I
Effects of elevated osmolarity buffer on release from peritoneal mast cells.
Cmax is the maximal concentration of histamine measured from each current spike. ISO, ISO buffer contained 150 mM NaCl.
Secretagogue [NaCl] Cmax
% histamine
spikes  0.4 M Spike frequency
mM M Hz
A23187 150 (ISO) 12.04  0.45 87.5 0.64
A23187 350 0.14  0.02 0 0.17
ISO after A23187 350 5.06  0.28 89.1 0.61
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Chromaffin Cells—In isotonic solution without Ca2, tran-
sient exposure of chromaffin cells to Ba2 (5 mM, 5 s) causes
exocytotic release of catecholamines (Fig. 3) (24). In isotonic
solution containing Ca2, transient exposure of chromaffin
cells to elevated KCl (60 mM, 5 s) also causes exocytotic release
of catecholamines (Fig. 4) (35). Cyclic voltammetry can be used
to monitor the release and can distinguish cells that secrete
norepinephrine from those that secrete epinephrine (36). Cyclic
voltammograms (37) also reveal that the foot present for many
exocytotic events is comprised of catecholamines (data not
shown). Release evoked by the two secretagogues is quite sim-
ilar (24) (Table II).
In hyperosmotic solutions (520 mM NaCl) without Ca2,
transient exposure to 5 mM Ba2 also results in exocytotic
spikes from chromaffin cells (Fig. 3), but they are less frequent
and much smaller in amplitude (Table II). Similar results are
obtained for K-induced release in hypertonic solutions (Fig. 4,
Table II). The maximal concentration of spikes in hypertonic
medium with Ba2 is only 7% and with K is only 10% of that
seen in isotonic medium. In all cases the cyclic voltammograms
revealed that the small, foot-like events were the same cate-
cholamine that the cell normally secreted. Thus, the results at
chromaffin cells are quite similar to those at mast cells: in
hyperosmotic solutions, release events of small amplitude can
be evoked, but their concentration and frequency is lower than
in isotonic solution.
Transient application of an isotonic solution to chromaffin
cells for 15 s at 2 min after exposure to either secretagogue in
hypertonic medium induced massive release (Table II, Figs. 3
and 4). In 27% of the chromaffin cells pretreated with 60 mM
KCl and 36% of the cells pretreated with Ba2, this release
consisted of one to two spikes with maximal concentrations
greater than 40 M that appeared to be compound exocytotic
events. In the remainder of cells, spikes were observed shortly
after exposure to isotonic buffer with a delay time of 4 s to the
first spike. The isotonic buffer caused cell swelling on a similar
time scale. The large spikes diminished immediately following
cessation of transient exposure to isotonic buffer. When cells
were completely restored to isotonic conditions, exposure to
either secretagogue evoked spikes with a normal frequency and
maximal concentrations (data not shown).
Fura-2 was used to monitor either intracellular Ba2 or Ca2
in these experiments. It is well established in isotonic solutions
that both secretagogues cause an immediate increase in intra-
cellular divalent ions (34), and this was replicated in this work
(data not shown). In hypertonic solutions, pressure ejection of
Ba2 or K similarly caused an elevation in intracellular diva-
lent ion concentrations. In the case of Ba2, the signal re-
mained elevated for greater than 3 min (Fig. 3) because intra-
cellular Ca2 stores do not effectively sequester it (38).
Following K in hypertonic solution, the divalent ion signal
returned to base-line levels 10 s after its application. Thus,
the observed, divalent ion entry accompanies the small release
events obtained in hypertonic solutions.
Fura-2 measurements were also made during reintroduction
of isotonic solution after exposure to secretagogues. The accom-
FIG. 2. Optical micrographs of a
mast cell during degranulation. a, ini-
tial view of the cell in hypertonic solution
(350 mM NaCl). b, cell following exposure
to A23187. c, same cell following subse-
quent exposure (10 s) to isotonic solution
(150 mM NaCl). d, five minutes after c.
FIG. 1. Cyclic voltammetric moni-
toring of exocytosis at a mast cell in
isotonic solution (150 mM NaCl) and
hypertonic solution (350 mM NaCl).
Left panel, typical release from a mast cell
exposed to A23187 in isotonic solution. A
different cell, in hypertonic solution, was
exposed to A23187 for 5 s during the first
dashed box (middle panel) and then ex-
posed to isotonic solution for 10 s during
the second dashed box (right panel). Color
plots: release events were monitored with
background subtracted, FSCV that allows
a simultaneous view of serotonin and his-
tamine (29). The potential applied to the
carbon fiber microelectrode is plotted on
the y axis (from 0.1 to 1.4 and back to
0.1 V versus a Ag/AgCl reference), while
the x axis is time. The current intensity is
encoded in color as indicated by the scale
bar (note change in scale bars). For sero-
tonin, the oxidation is maximal at 0.7 V,
and for histamine oxidation is maximal at
1.3 V. Middle trace, current arising from
oxidation of histamine. Upper trace,
fura-2 monitoring of intracellular diva-
lent ion concentration at a different cell.
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panying cell swelling and dye dilution complicates interpreta-
tion of the changes in divalent ions. There was no observable
change in the bound to free ratio at cells that had been exposed
to Ba2; however, results in cells that had been exposed to K
were equivocal.
Confocal Microscopy—To provide evidence that vesicles
fused with the plasma membrane in hypertonic solution, a
fluorescently labeled antibody to DH was employed. DH is a
vesicular enzyme that appears on the surface of chromaffin
cells following exocytosis (39). Exposure to Ba2 for 2 min in
FIG. 3. Cyclic voltammetric moni-
toring of exocytosis at a chromaffin
cell in isotonic (150 mM NaCl) and hy-
pertonic solution (520 mM NaCl). Left
panel, release from a cell in isotonic solu-
tion upon exposure to Ba2. The cell in
hypertonic solution (middle panel) was
exposed to Ba2 for 5 s during the first
dashed box and then exposed to isotonic
solution for 15 s during the second dashed
box (right panel). Color plots: release
events were monitored with FSCV. The
potential applied to the carbon fiber mi-
croelectrode is plotted on the y axis, while
the x axis is time. The current intensity is
encoded in color as indicated by the scale
bar (note change in scale bars). For epi-
nephrine, oxidation of the catechol to its
o-quinone occurs at 0.75 V with a second
peak at 1.5 V from the oxidation of the
secondary amine as described previously
(36). Middle trace, current arising from
oxidation of epinephrine at 0.75 V. Up-
per trace, fura-2 monitoring of intracellu-
lar divalent ion concentration at a differ-
ent cell.
FIG. 4. Cyclic voltammetric monitoring of exocytosis at a chromaffin cell in isotonic (150 mM NaCl) and hypertonic solution (520
mM NaCl). Left panel, release from a cell exposed to 60 mM K in isotonic solution. The cell in hypertonic solution was exposed to K for 5 s during
the first dashed box (middle panel) and then exposed to isotonic solution for 15 s during the second dashed box (right panel). Color plots: release
events were monitored with FSCV. The current intensity is encoded in color as indicated by the scale bar (note change in scale bars). Middle trace,
current arising from oxidation of epinephrine at 0.75 V. The experimental parameters are the same as those in Fig. 3. Upper trace, fura-2
monitoring of intracellular divalent ion concentration at a different cell.
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either isotonic (Fig. 5a) or hypertonic solutions (Fig. 5b) causes
DH localization on the cell perimeter. The fluorescence at the
cell surface, which is eight times more intense in cells stimu-
lated in isotonic solution, indicates vesicle-cell membrane fu-
sion has occurred under both conditions, exposing the vesicle
interior to the external solution. In both solutions, unstimu-
lated cells showed no fluorescence (data not shown).
A similar experiment was used to test vesicle lifetime at the
cell surface. With the same treatment as in Fig. 5a, but with a
20-min incubation in buffer before the addition of DH anti-
body, DH was not found on cell surfaces when stimulated in
isotonic medium (Fig. 5c). This is consistent with vesicle endo-
cytosis that occurs on a time scale much shorter than 20 min in
isotonic solutions (40). Supporting this conclusion, fluorescence
was found within cells that were stimulated to release in iso-
tonic solutions in the presence of DH antibody (Fig. 5e). In
contrast, DH antibody was present on cell surfaces stimulated
in hypertonic medium under all conditions, but was not seen to
incorporate within the cell (Fig. 5, d and f). The rate of endo-
cytosis is known to be lower in hypertonic solutions, consistent
with this finding (41).
DISCUSSION
In high osmolarity solutions, secretion from both mast and
chromaffin cells is dramatically altered. The results presented
here show that vesicle-cell membrane fusion can still occur
under these conditions, but that full extrusion of the vesicle
contents does not occur. Indeed, the fused vesicles in hyper-
tonic solution appear to be frozen at the cell surface, and only
release after swelling of the vesicle matrix is allowed to occur.
Previous studies have demonstrated that both chromaffin and
mast cell vesicles contract in response to hypertonic stress
without disruption of their stored contents (5). Indeed, the
chromaffin vesicle has been termed an ideal osmometer be-
tween 300 and 1000 mosM (6). The new finding of this work is
that high osmolarity solutions prevent full extrusion of vesicle
contents and allow temporal isolation of an intermediate state
in the sequence of events that occur during exocytosis, a state
we refer to as “kiss-and-hold.”
Hypertonic solutions clearly lower the rate of exocytosis at
both mast and chromaffin cells. This could arise from an in-
crease in actin filaments at the cell membrane as found in
neutrophils in hyperosmotic solutions (42), because the rate of
exocytosis in chromaffin cells depends on the degree of associ-
ation of actin filaments (43). However, previous visual studies
in high osmolarity solutions have shown that vesicle-cell mem-
brane fusion is not prevented at chromaffin or mast cells (17,
44, 45), nor in sea urchin eggs (46). In this work, vesicle-cell
membrane fusion is established in chromaffin cells by the pres-
ence of DH on the cell surface in both isotonic and hypertonic
medium. DH labeling is lowered in hypertonic solutions, cor-
FIG. 5. Confocal images of chromaffin cells stimulated to re-
lease under different conditions and stained with DH anti-
body. a, c, and e, results obtained in isotonic solution. b, d, and f,
results obtained in hypertonic (520 mM NaCl) solution. a and b, cell was
fixed after 2-min exposure to 5 mM Ba2 followed by DH antibody
staining. c and d, cells were exposed to Ba2 as in a and rinsed for 20
min without Ba2 before fixation and staining. e and f, cells were
stimulated as in a but in the presence of anti-DH antibody to reveal
endocytosis.
FIG. 6. Model for separation of vesicle fusion and subsequent
extrusion of contents. When stimulated in hypertonic solution, ves-
icles dock with the plasma membrane and unassociated contents can
diffuse through the fusion pore (upper). Subsequent exposure to isotonic
solution causes expansion of the vesicle matrix and extrusion of con-
tents (lower).
TABLE II
Effects of elevated osmolarity buffer on release from chromaffin cells stimulated with 5 mM Ba2 or 60 mM K.
Cmax values are measured from catecholamine oxidative peak. ISO, ISO buffer contained 150 mM NaCl.
Secretagogue [NaCl] (mM) Cmax % spikes  2 M Total spike frequency
M Hz
Ba2 150 (ISO) 13.86  1.77 89.5 1.18
Ba2 520 1.36  0.14 19.6 0.15
ISO after Ba2 520 7.08  1.41 72.9 0.23
K 150 (ISO) 12.22  1.23 93.2 1.66
K 520 0.82  0.06 2.6 0.12
ISO after K 520 3.68  0.52 47.3 0.22
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relating well with the decreased frequency of electrochemically
detected spikes. At mast cells, visual evidence for vesicle-cell
membrane fusion was not obtained in hypertonic medium, al-
though secretion was clearly evident by the cyclic voltammetry.
The secretory events that are seen are so small that they
resemble the feet that precede some exocytotic events in iso-
osmolar solutions at both types of cells in hypertonic media.
This is the expected outcome if vesicle fusion occurred in hy-
pertonic solutions with only minor extrusion of the contents.
Despite their small size, the cyclic voltammograms establish
that the substances detected are those stored in the vesicles.
All of the evidence from both cell types indicates that the
small size of the spikes obtained in hypertonic medium is a
consequence of inhibition of vesicle-matrix dissociation. The
association of the vesicle contents in chromaffin cells has been
characterized as a “dynamic viscous solution that is stabilized
by ternary complex formation” (10) and is also well documented
in mast cells (47). Upon exposure to the extracellular solution
through the fusion pore, at the initial “kiss,” exchange between
the vesicular interior and the extracellular fluid begins. Nor-
mally the matrix dissociation and extrusion of its contents
relies on hydration, with its accompanying matrix swelling,
that is driven by a physical or chemical gradient across the
fusion pore. By removing the osmotic gradient in hypertonic
solutions, one of the driving forces for dissociation and extru-
sion is dissipated. The small amount of secretion that does
occur could arise from components originally in an unassoci-
ated state or a small amount of matrix dissociation that occurs
at the fusion pore, but which is unable to propagate into the
remainder of the vesicle. Because rates of endocytosis are low-
ered in hypertonic solutions, the fused, intact vesicle “holds” at
the cell surface for an extended period of time.
The frozen, fused vesicle state established in hypertonic me-
dium is destroyed once the osmotic gradient is re-established.
This occurs with the transient isotonic exposure that evokes
multiple spikes on the time scale of cellular swelling. In mast
cells, the maximal concentration of these spikes is consistent
with extrusion of contents from previously fused vesicles. At
chromaffin cells, the maximal concentration and time course of
some observed spikes are larger than under normal exocytotic
conditions, consistent with multiple, simultaneous secretory
events. For cells stimulated with K, the original stimulus is no
longer present upon isotonic solution exposure, and yet secre-
tion is still observed. This strongly suggests that the observed
spikes arise from previously fused vesicles. With Ba2 at chro-
maffin cells and with mast cells, the isotonic-evoked spikes are
unaccompanied by an increase in intracellular divalent ions.
Thus, it is clear that the discrete processes of vesicle fusion and
vesicle extrusion have been temporally separated. Concentra-
tion and pH gradients between the vesicle matrix and the
external solution may exert similar effects (24, 25). Indeed,
chromaffin cells previously stimulated with Ba2 in hypertonic
solutions did not release when exposed to isotonic buffer at pH
5.5 (data not shown). Thus, re-establishing an osmotic gradient
is not sufficient to unravel the kiss and hold state; the pH
gradient is necessary as well.
All of these results are consistent with recent mathematical
models for the swelling of secretory granules after fusion pore
formation and its role in extrusion of granule contents (18, 48).
These models indicate that the hydration and swelling of the
vesicle matrix cause an enlargement of the fusion pore leading
to its destabilization. Thus, normally in mast and chromaffin
cells the pore expansion of the vesicle occurs rapidly, driven by
the irreversible swelling of the matrix, and results in full in-
corporation of the vesicle membrane and extrusion of vesicular
contents as illustrated in the sequence of steps in Fig. 6. By
removing the driving force for swelling, we were able to isolate
the intermediate kiss-and-hold state. The mathematical mod-
els predict that “kiss-and-run” events, events where fusion pore
formation allows escape of some transmitter followed by vesic-
ular retreat from the cellular membrane without fully fusing,
are unlikely under normal conditions at cells with large vesi-
cles. Consistent with these models, all fusion pore events in
mast cells are followed by complete fusion of the vesicle with
the cellular membrane and subsequent release (15). Patch-
amperometry studies on chromaffin cells reveal only 10% of the
observed fusion events are kiss-and-run (16), but these occur-
rences are increased with elevated external Ca2 concentra-
tions (49). In the absence of endocytosis caused by elevated
osmolarity, one would expect these events to be restricted to
the cell membrane, as shown in this work, until acted upon by
external forces. For small vesicles, the force of matrix expan-
sion is insufficient to destabilize the fusion pore, and kiss-and-
run is more likely. This has also been observed for small clear
vesicles at hippocampal synapses (50).
The hypertonically constructed kiss-and-hold configuration
inhibits the dissociation of matrix constituents following vesi-
cle fusion with the cell membrane. This provides access to the
vesicle interior while maintaining the viability of the cell,
which may allow for a more complete understanding of the
complex interaction of molecules within the vesicle matrix in
their natural environment as well as a glimpse of their disso-
ciation during exocytosis. Under normal physiological condi-
tions, full fusion and extrusion of vesicular contents is predom-
inant at both mast and chromaffin cells, relying on the
destabilization of the granule matrix through swelling to rap-
idly pass through the kiss-and-hold state.
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